A Single-dose, Open-label Clinical Study to Evaluate the Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects
Latest Information Update: 27 Apr 2023
At a glance
- Drugs MY-008211A (Primary)
- Indications IgA nephropathy; Paroxysmal nocturnal haemoglobinuria
- Focus Pharmacokinetics
- Sponsors Wuhan Createrna Science and Technology
Most Recent Events
- 27 Apr 2023 New trial record